Jeff Yass’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.93M Sell
142,683
-99,271
-41% -$2.27M ﹤0.01% 5682
2026
Q1
$5.33M Sell
241,954
-120,830
-33% -$2.1M ﹤0.01% 4120
2025
Q4
$4.28M Sell
362,784
-132,147
-27% -$1.7M ﹤0.01% 4269
2025
Q3
$7.84M Buy
494,931
+53,789
+12% +$780K ﹤0.01% 3363
2025
Q2
$5.05M Sell
441,142
-308,445
-41% -$3.48M ﹤0.01% 3946
2025
Q1
$10.1M Buy
749,587
+403,266
+116% +$6.7M ﹤0.01% 2520
2024
Q4
$5.85M Buy
346,321
+138,624
+67% +$2.7M ﹤0.01% 3366
2024
Q3
$4.22M Buy
207,697
+152,315
+275% +$3.11M ﹤0.01% 3890
2024
Q2
$1.25M Sell
55,382
-26,289
-32% -$688K ﹤0.01% 6056
2024
Q1
$2.14M Sell
81,671
-309,521
-79% -$8.82M ﹤0.01% 5172
2023
Q4
$12.3M Buy
391,192
+347,467
+795% +$9.43M ﹤0.01% 2368
2023
Q3
$1.23M Sell
43,725
-22,080
-34% -$758K ﹤0.01% 6176
2023
Q2
$2.43M Buy
65,805
+8,633
+15% +$264K ﹤0.01% 4751
2023
Q1
$1.71M Buy
57,172
+21,823
+62% +$719K ﹤0.01% 5483
2022
Q4
$1.08M Sell
35,349
-220,576
-86% -$6.62M ﹤0.01% 6010
2022
Q3
$6.31M Buy
255,925
+222,271
+660% +$7.33M ﹤0.01% 2812
2022
Q2
$1.08M Sell
33,654
-134,441
-80% -$4.94M ﹤0.01% 6342
2022
Q1
$5.29M Buy
168,095
+151,403
+907% +$4.74M ﹤0.01% 3542
2021
Q4
$560K Sell
16,692
-26,148
-61% -$815K ﹤0.01% 8877
2021
Q3
$1.25M Buy
42,840
+16,993
+66% +$550K ﹤0.01% 6986
2021
Q2
$899K Buy
25,847
+13,211
+105% +$437K ﹤0.01% 8058
2021
Q1
$353K Sell
12,636
-267,176
-95% -$7.11M ﹤0.01% 10266
2020
Q4
$6.94M Sell
279,812
-58,647
-17% -$1.4M ﹤0.01% 2950
2020
Q3
$7.08M Sell
338,459
-204,286
-38% -$3.94M ﹤0.01% 2630
2020
Q2
$8.33M Buy
542,745
+109,791
+25% +$1.39M ﹤0.01% 2359
2020
Q1
$3.84M Buy
432,954
+118,029
+37% +$1.7M ﹤0.01% 2921
2019
Q4
$5.7M Buy
314,925
+98,798
+46% +$1.64M ﹤0.01% 2798
2019
Q3
$3.23M Sell
216,127
-39,603
-15% -$644K ﹤0.01% 3377
2019
Q2
$6.14M Buy
255,730
+246,122
+2,562% +$7.25M ﹤0.01% 2444
2019
Q1
$357K Sell
9,608
-141,650
-94% -$5.15M ﹤0.01% 6910
2018
Q4
$4.27M Buy
+151,258
New +$4.78M ﹤0.01% 2474
2018
Q3
Sell
-17,279
Closed -$756K 9263
2018
Q2
$766K Buy
+17,279
New +$860K ﹤0.01% 5937
2018
Q1
Sell
-111,788
Closed -$5.59M 9350
2017
Q4
$5.6M Sell
111,788
-17,928
-14% -$939K ﹤0.01% 2418
2017
Q3
$6.57M Sell
129,716
-620,847
-83% -$29.3M ﹤0.01% 2188
2017
Q2
$28.5M Buy
750,563
+475,635
+173% +$18.8M 0.01% 898
2017
Q1
$10.6M Buy
274,928
+185,534
+208% +$5.58M 0.01% 1578
2016
Q4
$1.97M Sell
89,394
-38,205
-30% -$784K ﹤0.01% 4094
2016
Q3
$2.04M Hold
127,599
﹤0.01% 3537
2016
Q2
$1.05M Hold
127,599
﹤0.01% 4785
2016
Q1
$893K Sell
127,599
-447,220
-78% -$2.25M ﹤0.01% 5314
2015
Q4
$3.08M Buy
574,819
+392,400
+215% +$2.51M ﹤0.01% 3230
2015
Q3
$1.18M Buy
+182,419
New +$1.91M ﹤0.01% 5359

Other funds holding CC

Jeff Yass's CC Position: Q2 2026 in Review

Jeff Yass reduced its Chemours (CC) stake by 41% in Q2 2026, selling an estimated $2.27M and leaving 142,683 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #5682.

Jeff Yass first reported a position in CC in Q3 2015 and has held it in 42 quarters since. The position peaked at $28.5M in Q2 2017. 470 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Jeff Yass held 142,683 shares of Chemours worth $2.93M as of Q2 2026.
  • Jeff Yass sold 99,271 Chemours shares in Q2 2026, an estimated $2.27M.
  • Chemours made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5682 holding.
  • Jeff Yass first reported a position in Chemours in Q3 2015 and has held it in 42 quarters since.
  • Jeff Yass's Chemours position peaked at $28.5M in Q2 2017.
  • 470 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.